{"name":"Innogene Kalbiotech Pte. Ltd","slug":"innogene-kalbiotech-pte-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"6% Hydroxy Ethyl Starch","genericName":"6% Hydroxy Ethyl Starch","slug":"6-hydroxy-ethyl-starch","indication":"Other","status":"marketed"},{"name":"Hyperosmolar sodium lactate","genericName":"Hyperosmolar sodium lactate","slug":"hyperosmolar-sodium-lactate","indication":"Elevated intracranial pressure","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Hypertonic lactate","genericName":"Hypertonic lactate","slug":"hypertonic-lactate","indication":"Resuscitation in hemorrhagic shock and trauma","status":"marketed"}]}],"pipeline":[{"name":"Hypertonic lactate","genericName":"Hypertonic lactate","slug":"hypertonic-lactate","phase":"marketed","mechanism":"Hypertonic lactate provides osmotic support and metabolic substrate to restore cellular energy and reduce intracranial pressure in critically ill patients.","indications":["Resuscitation in hemorrhagic shock and trauma","Cerebral edema and elevated intracranial pressure","Septic shock and severe metabolic acidosis"],"catalyst":""},{"name":"6% Hydroxy Ethyl Starch","genericName":"6% Hydroxy Ethyl Starch","slug":"6-hydroxy-ethyl-starch","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hyperosmolar sodium lactate","genericName":"Hyperosmolar sodium lactate","slug":"hyperosmolar-sodium-lactate","phase":"phase_3","mechanism":"Hyperosmolar sodium lactate increases serum osmolality to draw fluid from intracellular and interstitial spaces into the intravascular compartment, reducing intracranial pressure and improving cerebral perfusion.","indications":["Elevated intracranial pressure","Traumatic brain injury","Acute ischemic stroke"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPMVBveFU2SmJoTTFOM3FuQWFDQVlrQ3ktMUZGTmhqREpjV3JUNENnME5CRVYxeWN3RERWQWgtTEYzTVNBX3RNWUpYbFpnS2JXQlh2cTh6MjRvcE5TcVRUX0tROUpHSHBsRmdmVmM3dTVOSWhNS2tGOVVUN0M2Y2hRdXkwZlgtRUg4bmFLUENyRlZyVkRqUGFJZWhwWWZFWjd6eHNTOTVQNmxCM1JDb3RSTGI1Wm5qNkxlTmNIb2dPbnY?oc=5","date":"2021-01-27","type":"pipeline","source":"Next Unicorn Ventures","summary":"Indonesian life sciences company KGBio receives US$55 million investment from General Atlantic - Next Unicorn Ventures","headline":"Indonesian life sciences company KGBio receives US$55 million investment from General Atlantic","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":2,"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}